Goldman Sachs upgraded Emerson (NYSE: EMR) from Neutral to Buy and raises their price target to $69 from $62 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE